Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development

Nature Immunology

Volumn 10, Issue 10, 2009, Pages 1110-1117

  Mandal, Malay ^a   Powers, Sarah E ^a   Ochiai, Kyoko ^a   Georgopoulos, Katia ^b   Kee, Barbara L ^a   Singh, Harinder ^a   Clark, Marcus R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIOLOS TRANSCRIPTION FACTOR; CYCLIN D3; IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN KAPPA CHAIN; INHIBITOR OF DIFFERENTIATION 3; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAS PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; BINDING AFFINITY; CELL CYCLE REGULATION; CELL FATE; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE; CELL DIFFERENTIATION; CYCLINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; IMMUNOBLOTTING; IMMUNOGLOBULIN LIGHT CHAINS; MAP KINASE KINASE KINASES; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RAS PROTEINS; RECEPTORS, INTERLEUKIN-7; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 70349445270     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1785     Document Type: Article

References (45)

1. Pelanda, R., Braun, U., Hobeika, E., Nussenzweig, M.C. & Reth, M. B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-α and Ig-β. J. Immunol. 169, 865-872 (2002).
2. Shimizu, T., Mundt, C., Licence, S., Melchers, F. & Martensson, I. VpreB1/VpreB2/λ 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. J. Immunol. 168, 6286-6293 (2002).
3. Erlandsson, L. et al. Both the pre-BCR and the IL-7Rα are essential for expansion at the pre-BII cell stage in vivo. Eur. J. Immunol. 35, 1969-1976 (2005).
4. Clark, M.R., Cooper, A.B., Wang, L. & Aifantis, I. The pre-B cell receptor in B cell development: Recent advances, persistent questions and conserved mechanisms. Curr. Top. Microbiol. Immunol. 290 87-104 (2005).
5. Geier, J.K. & Schlissel, M.S. Pre-BCR signals and the control of Ig gene rearrangements. Semin. Immunol. 18, 31-39 (2006).
6. Bassing, C.H. & Alt, F.W. The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst.) 3, 781-796 (2004).
7. Melchers, F. The pre-B-cell receptor: Selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nat. Rev. Immunol. 5 578-584 (2005).
8. van Loo, P.F., Dingjan, G.M., Maas, A. & Hendriks, R.W. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling. Immunity 27, 1-13 (2007).
9. Jumaa, H., Mitterer, M., Reth, M. & Nielsen, P.J. The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Eur. J. Immunol. 31, 2164-2169 (2001).
10. + stage. Blood 109, 3377-3384 (2007).
11. Bai, L. et al. Phospholipase Cγ2 contributes to light-chain gene activation and receptor editing. Mol. Cell. Biol. 27, 5957-5967 (2007).
12. Young, F. et al. Influnence of immunoglobulin heavy- and light-chain expression on B-cell differentation. Genes Dev. 8 1043-1057 (1994).
13. Iritani, B.M., Forbush, K.A., Farrar, M.A. & Perlmutter, R.M. Control of B cell development by Ras-mediated activation of Raf. EMBO J. 16, 7019-7031 (1997).
14. Shaw, A.C., Swat, W., Ferrini, R., Davidson, L. & Alt, F.W. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J. Exp. Med. 189, 123-129 (1999).
15. Shaw, A.C., Swat, W., Davidson, L. & Alt, F.W. Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras. Proc. Natl. Acad. Sci. USA 96, 2239-2243 (1999).
16. Lu, R., Kay, L., Lancki, D.W. & Singh, H. IRF-4,8 orchestrate the pre-B to B transition in lymphocyte development. Genes Dev. 17, 1703-1708 (2003).
17. Ma, S., Pathak, S., Trinh, L. & Lu, R. Interferon regulatory factors 7 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B cell receptor and promote cell-cycle withdrawal in pre-B cell development. Blood 111, 1396-1403 (2008).
18. Johnson, K. et al. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 28, 335-345 (2008).
19. Schlissel, M.S. & Baltimore, D. Regulation of activation and recombination of the murine Ig. locus. Immunol. Rev. 200, 215-223 (2004).
20. Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343-353 (2000).
21. Inlay, M.A., Tian, H., Lin, T. & Xu, Y. Important roles for E protein binding sites within the immunoglobulin κ chain intronic enhance in activating V-κJ-κ rearrangement. J. Exp. Med. 200, 1205-1211 (2004).
22. Lazorchak, A.S., Schlissel, M.S. & Zhuang, Y. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin κ locus in pre-B cells. Mol. Cell. Biol. 26, 810-821 (2006).
23. Kee, B.L., Quong, M.W. & Murre, C. E2A proteins: Essential regulators at multiple stages of B-cell development. Immunol. Rev. 175, 138-149 (2000).
24. Cooper, A.B. et al. A unique function for cyclin D3 in early B cell development. Nat. Immunol. 7, 489-497 (2006).
25. Herzog, S. et al. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat. Immunol. 9, 623-631 (2008).
26. Fleming, H.E. & Paige, C.J. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15, 521-531 (2001).
27. Halcomb, K.E. et al. Btk and phospholipase C.2 can function independently during B cell development. Eur. J. Immunol. 37 1033-1042 (2007).
28. Morgan, B. et al. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16, 2004-2013 (1997).
29. Thompson, E.C. et al. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 26, 335-344 (2007).
30. Wang, J.H. et al. Aiolos regulates B cell activation and maturation to effector state. Immunity 9, 543-553 (1998).
31. Georgopoulos, K. Transcription factors required for lymphoid lineage commitment. Curr. Opin. Immunol. 9, 222-227 (1997).
32. Meyer, K.B., Skogberg, M., Margenfeld, C., Ireland, J. & Petterson, S. Repression of the immunoglobulin heavy chain 3′ enhancer by helix-loop-helix protein Id3 via a functionally important E47/E12 binding site: Implications for developmental control of enhancer function. Eur. J. Immunol. 25, 1770-1777 (1995).
33. Wilson, R.B. et al. Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: Implications for B-lymphoid-cell development. Mol. Cell. Biol. 11, 6185-6191 (1991).
34. Bertolino, E. et al. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat. Immunol. 6, 836-843 (2005).
35. Palmer, M.J. et al. Interleukin-7 receptor signaling network: An integrated systems perspective. Cell. Mol. Immunol. 5, 79-89 (2008).
36. Onishi, T. et al. Identification and charactgerization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18, 3871-3879 (1998).
37. Kelly, E., Won, A., Refaeli, Y. & Parijs, L.V. IL-2 and related cytokines can promote T cell survival by activating AKT. J. Immunol. 168, 597-603 (2002).
38. Goetz, C.A., Harmon, I.R., O'Neil, J.J., Burchill, M.A. & Farrar, M.A. STAT5 activation underlies IL7 receptor-dependent B cell development. J. Immunol. 172, 4770-4778 (2004).
39. Crespo, P. & Leon, J. Ras proteins in the control of the cell cycle and cell differentiation. Cell. Mol. Life Sci. 57, 1613-1636 (2000).
40. Bain, G. et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2, 165-171 (2001).
41. Hsu, L.Y. et al. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19, 105-117 (2003).
42. Yasuda, T. et al. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28, 499-508 (2008).
43. Walker, S.B., Nelson, E.A. & Frank, D.A. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene 26, 224-233 (2006).
44. Hennighausen, L. & Robinson, G.W. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev. 22, 711-721 (2008).
45. Amin, R.H. & Schlissel, M.S. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9, 613-622 (2008).